当前位置: 首页 » 政策法规 » 国外法规 »(EU) 2015/391:拒绝批准某些用于食品涉及儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods and referring to children's development and health)

(EU) 2015/391:拒绝批准某些用于食品涉及儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods and referring to children's development and health)

扫描二维码 分享好友和朋友圈
放大字体  缩小字体 2015-03-13 04:22:53  来源:EUROPE  浏览次数:3079
核心提示:2015年3月10日,欧盟发布委员会条例(EU) 2015/391,拒绝批准3种食品健康声称,分别是:1)浓缩β—棕榈酸酯有助于软化粪便硬度,增加儿童的排便次数;2)胆碱是0~3岁婴幼儿大脑发育所必需的物质;3)复合碳水化合物有助于增加儿童饱腹感。
发布单位
EUROPEAN COMMISSION
EUROPEAN COMMISSION
发布文号 (EU) 2015/391
发布日期 2015-03-10 生效日期 暂无
有效性状态 废止日期 暂无
备注 2015年3月10日,欧盟发布委员会条例(EU) 2015/391,拒绝批准3种食品健康声称,分别是:1)浓缩β—棕榈酸酯有助于软化粪便硬度,增加儿童的排便次数;2)胆碱是0~3岁婴幼儿大脑发育所必需的物质;3)复合碳水化合物有助于增加儿童饱腹感。

  COMMISSION REGULATION (EU) 2015/391

  of 9 March 2015

  refusing to authorise certain health claims made on foods and referring to children's development and health

  (Text with EEA relevance)

  THE EUROPEAN COMMISSION,

  Having regard to the Treaty on the Functioning of the European Union,

  Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (1), and in particular Article 17(3) thereof,

  Whereas:

  (1)

  Pursuant to Regulation (EC) No 1924/2006 health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.

  (2)

  Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State. The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as ‘the Authority’.

  (3)

  Following receipt of an application the Authority is to inform without delay the other Member States and the Commission thereof, and to deliver an opinion on the health claim concerned.

  (4)

  The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.

  (5)

  Following an application from Specialised Nutrition Europe (formerly European Dietetic Food Industry Association), submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to beta-palmitate and contribution to softening stools (Question No EFSA-Q-2008-174 (2)). The claim proposed by the applicant was worded, inter alia, as follows: ‘Beta-palmitate enrichment contributes to soften stool consistency which helps to increase their frequency’.

  (6)

  On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 21 February 2014, that a cause and effect relationship has not been established between the consumption of beta-palmitate and softening of stools. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

  (7)

  Following an application from Specialised Nutrition Europe, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of choline and ‘development of brain’ (Question No EFSA-Q-2008-134 (3)). The claim proposed by the applicant was worded, inter alia, as follows: ‘Choline is needed for the development of brain of infants and young children from birth to three years’.

  (8)

  On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 5 May 2014, that the claimed effect, ‘development of brain’ for infants and young children from birth to three years in relation to dietary choline, was not sufficiently defined for a scientific evaluation. In particular, the Authority considered that from the references provided by the applicant it is not possible to establish the physiological function of the nervous system that is the subject of the health claim and therefore the claimed effect is general and non-specific. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

  (9)

  Following an application from Specialised Nutrition Europe, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to ‘complex carbohydrates’ and ‘contribute to satiety’ (Question No EFSA-Q-2008-131 (4)). The claim proposed by the applicant was worded, inter alia, as follows: ‘Complex carbohydrates contribute to satiety’.

  (10)

  On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 5 May 2014, that a cause and effect relationship has not been established between the consumption of ‘complex carbohydrates’ and a beneficial physiological effect for infants and young children (from birth to three years of age). According to the Authority, the applicant did not provide evidence to establish that an increase in satiety is a beneficial physiological effect for infants and young children. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

  (11)

  In accordance with Article 28(6) of Regulation (EC) No 1924/2006, health claims referred to in its Article 14(1)(b) and not authorised by a decision pursuant to Article 17(3) of Regulation (EC) No 1924/2006 may continue to be used for six months after such decision is taken, provided the application for authorisation was made before 19 January 2008. Accordingly, as the health claims listed in the Annex to this Regulation fulfil the above conditions, the transitional period laid down in that Article should apply.

  (12)

  The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

  HAS ADOPTED THIS REGULATION:

  Article 1

  1.   The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 14(1) of Regulation (EC) No 1924/2006.

  2.   However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation may continue to be used for a maximum period of six months after the entry into force of this Regulation.

  Article 2

  This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

  This Regulation shall be binding in its entirety and directly applicable in all Member States.

  Done at Brussels, 9 March 2015.

  For the Commission

  The President

  Jean-Claude JUNCKER
 

ANNEX
Rejected health claims

Application — Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 14(1)(b) health claim referring to children's development and health
Beta-palmitate
Beta-palmitate enrichment contributes to soften stool consistency which helps to increase their frequency
Q-2008-174
Article 14(1)(b) health claim referring to children's development and health
Choline
Choline is needed for the development of brain of infants and young children from birth to three years
Q-2008-134
Article 14(1)(b) health claim referring to children's development and health
‘Complex carbohydrates’
Complex carbohydrates contribute to satiety
Q-2008-131

食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务。
电询:0535-2129301
QQ:2891238009
食品标法圈
实时把握食品标法动态
请扫码关注食品标法圈

声明:

① 凡本网所有原始/编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”。
② 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。
※ 邮箱:law#foodmate.net(发邮件时请将#换成@) QQ:139307733

 
 
[ 政策法规搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 [ 关闭窗口 ]

 

 
 
按分类浏览
国家法规 (11453) 国外法规 (3603)
地方法规 (40324) 法规动态 (210)
法规解读 (2671) 其他法规 (512)
推荐国外法规
点击排行
按国家或地区浏览

法规中心  关于我们  广告业务  联系我们  信息服务

Processed in 2.855 second(s), 10 queries, Memory 4.49 M